Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Tsuda, Kenshiro ^a   Yamanaka, Keiichi ^a   Kitagawa, Hiroshi ^a   Akeda, Tomoko ^a   Naka, Masanao ^a   Niwa, Kaori ^a   Nakanishi, Takehisa ^a   Kakeda, Masato ^a   Gabazza, Esteban C ^b   Mizutani, Hitoshi ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; TACROLIMUS; CALCINEURIN; CYCLOSPORIN; CYTOKINE; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY T LYMPHOCYTE; NORMAL HUMAN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; BIOSYNTHESIS; CELL DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; HELPER CELL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; T LYMPHOCYTE;

ADULT; CALCINEURIN; CELL DIFFERENTIATION; CYCLOSPORINE; CYTOKINES; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; MALE; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TACROLIMUS;

EID: 84857124663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031465     Document Type: Article

References (15)

1. Schulze-Koops H, Kalden JR, (2001) The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 15: 677-691.
2. Ioannou Y, Isenberg DA, (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43: 1431-1442.
3. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG, (1999) The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752-759.
4. Del Prete G, (1992) Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 47: 450-455.
5. Yamanaka K, Mizutani H, (2011) The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Current problems in dermatology 41: 80-92.
6. Nakanishi K, Tsutsui H, Yoshimoto T, (2010) Importance of IL-18-induced super Th1 cells for the development of allergic inflammation. Allergology international: official journal of the Japanese Society of Allergology 59: 137-141.
7. Grinyo JM, Cruzado JM, Millan O, Caldes A, Sabate I, et al. (2004) Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts. Transplantation 78: 1400-1403.
8. Kobayashi T, Momoi Y, Iwasaki T, (2007) Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells. J Vet Med Sci 69: 887-892.
9. Yamamoto T, Nishioka K, (2006) Successful treatment with topical tacrolimus for oral psoriasis. J Eur Acad Dermatol Venereol 20: 1137-1138.
10. Brune A, Miller DW, Lin P, Cotrim-Russi D, Paller AS, (2007) Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol 24: 76-80.
11. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
12. Moseley TA, Haudenschild DR, Rose L, Reddi AH, (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14: 155-174.
13. Bettelli E, Oukka M, Kuchroo VK, (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8: 345-350.
14. Kiani A, Rao A, Aramburu J, (2000) Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12: 359-372.
15. Seder RA, Germain RN, Linsley PS, Paul WE, (1994) CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J Exp Med 179: 299-304.